u/Less_Donkey_4041

Hi everyone,

If there are any NIH GMS or others with recent experience, I’d really appreciate your guidance.

We’ll be submitting our first no-cost extension, and the project end date is 9/30/2026. I had a few questions:

For the first NCE, is it still grantee-approved and submitted directly in eRA Commons using the NCE button? Do we need to wait until the 90-day window (around July 1) for that option to appear, and then have the AOR submit it with no additional documents?

Or are people seeing cases where it needs to go through the prior approval process instead, with supporting documents (e.g., budget, progress update)? If so, can that be submitted earlier than the 90-day window (like May or June), or do you still need to wait?

Also, is it okay to reach out to the GMS ahead of time (May–June) to discuss the NCE? If you’ve done that, what kind of information or documents did they typically ask for?

Just trying to understand current practice, not older guidance. Really appreciate any recent insights—thanks!

For an NIH resubmission, is it okay to switch the Contact PI and MPI (A was Contact PI, B MPI → now B Contact PI, A MPI)? Any concerns, and is there an NIH reference confirming this?

Since the MFTRP certification language is already included in the new Other Support Common Form (RDS), are you still uploading a separate certification in RPPR Section G.1?

Quick JIT question—when preparing Other Support, do you include the application that triggered the JIT under pending, or leave it out?

If anyone has an official NIH link on this, I’d really appreciate it!